Droplet Biosciences, Inc Alternatives & Competitors
12 companies similar to Droplet Biosciences, Inc — Harnessing lymphatic fluid's powerful insights to improve cancer care through th...
Companies similar to Droplet Biosciences, Inc
-logo.jpg "Foresight Diagnostics (a Natera company)"){kind=logo}
Foresight Diagnostics (a Natera company)
Precision medicine company dedicated to improving the lives of cancer patients through imp...
Boulder, United States
CellMax Life
Liquid biopsy company focused on cancer screening with a proprietary platform for detectin...
Sunnyvale, United States
Predicine
Advancing precision medicine through next-generation liquid biopsy oncology platform
Hayward, United States
Personalis, Inc.
Ultrasensitive ctDNA testing
Fremont, United States
Rival Readout
Competing with Droplet Biosciences, Inc? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
SmartCatch
For a reliable liquid biopsy accessible to everyone
Toulouse, France
Elphogene, s.r.o.
Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby...
Czech Republic
Beijing, China
GILUPI GmbH
Advancing diagnostic procedures for precision medicine
Potsdam, Germany
ARNA Genomics
Pioneering early cancer diagnosis through advanced fluid biopsy technology
Hedera Dx
Modern cancer care for the next billion people
Epalinges, Switzerland
RhoDx, Inc.
Reducing Cancer Morbidity and Mortality through Early Detection and Monitoring.
United States
About Droplet Biosciences, Inc
Droplet Biosciences, Inc is revolutionizing cancer care with its pioneering approach to molecular residual disease (MRD) detection through lymphatic fluid analysis. Founded in 2021, this United States-based healthcare startup is breaking new ground with its first lymph liquid biopsy. Its slogan, "Harnessing lymphatic f...
LymphDetect™ Platform, Lymph Fluid Profiling, Cancer Recurrence Risk Assessment, Surgical Drain Fluid Analysis
Oncologists, Surgeons, Cancer Research Institutions, Pharmaceutical Companies, Healthcare Providers
Liquid Biopsy, Lymphatic Fluid Analysis, Molecular Residual Disease, Circulating Tumor DNA, Oncology Diagnostics, Adjuvant Treatment Guidance, Precision Oncology, Cancer Care Innovation, Tumor Resection Analysis, Biofluid Utilization, Genomics In Cancer Detection, Surgical Drain Fluid Analysis, CtDNA Detection, Cancer Molecular Insights
B2B, B2D, Platform
Service Fee, One Time Purchase, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Droplet Biosciences, Inc: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Droplet Biosciences, Inc on 28 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
